Evicenter
P&T meetings

Emcitate (tiratricol)

MCT8 deficiency

Last updated
78 sources

Product information and disease descriptionPlace of product in therapyDisease description

Clinical presentation - signs and symptoms

10 evidence topics · 7 sources

Developmental milestones: Japanese nationwide survey
FindingParticipants with finding (evaluable denominator in label)
Completion of head control, n = 28“7 (25 %)”
Able to keep sitting, n = 28“0 (0 %)”
Able to speak a word, n = 27“0 (0 %)”
Abnormal sleep rhythm, n = 27“9 (33 %)”
Feeding difficulty, n = 26“4 (15 %)”
Cardiovascular and nutritional manifestations: international natural-history cohort
ManifestationAffected participants and evaluable denominator
Elevated systolic blood pressure above the 90th percentile“25 (53%) of 47”
Premature atrial contractions“34 (76%) of 45”
Resting tachycardia“20 (31%) of 64”
Underweight“59 (71%) of 83”